Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1842)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2025 (publication date) through Dec 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Liu HR. Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression. World J Gastroenterol 2025; 31(20): 106443 [PMID: 40495945 DOI: 10.3748/wjg.v31.i20.106443] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Liu HR. Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression. World J Gastroenterol 2025; 31(20): 106443 [PMID: 40495945 DOI: 10.3748/wjg.v31.i20.106443] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i20/106443.htm |
| Number | Citing Articles |
| 1 |
Peiyuan Wang, Suyu Chen, Mengxia Lei, Yujie Chen, Hao He, Peng Chen, Weijie Chen, Hang Zhou, Feng Wang, Derong Zhang. METTL3-mediated m6A methylation of LncRNA DUXAP8 promoted esophageal squamous cell carcinoma progression by activating the PI3K/AKT signaling pathway. Cell Division 2025; doi: 10.1186/s13008-025-00174-w
|
| 2 |
Zhenrui Cao, Haiyan Wang, Yanlin Li, Siying Ye, Jingyao Lin, Tuoyu Li, Jiajie Leng, Yingjiu Jiang, Mengjun Bie, Letai Li. The global burden and trends of esophageal cancer caused by smoking among men from 1990 to 2021 and projections to 2040: An analysis of the Global Burden of Disease 2021. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-03315-7
|
| 3 |
Wan Lin, Ruizhi Cai, Weining Fan, Xiaoxu Zhang, Fang He, Yu Miao, Haiquan Qian, Wanli Zhao, Yongchao Zhu. MiR-5095 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting CEACAM5. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-23669-6
|
| 4 |
Weikang Su, Zhiling Zhong, Huazhi Li, Lingjia Meng, Xinqiang Zhong. The diagnostic and predictive value of LncRNA PANDAR in gastric cancer and its regulation of gastric cancer progression via miR-637. Hereditas 2025; 162(1) doi: 10.1186/s41065-025-00511-7
|
| 5 |
Yufei Wang, Xin Yin, MeiDing Wang, Meng Zhu, Yingwei Xue. LRP12 promotes gastric cancer progression through AKT/mTOR signaling and M2 macrophage-mediated immunosuppression. Scientific Reports 2025; doi: 10.1038/s41598-025-28503-7
|
| 6 |
Yuanqing Zhao, Jin Xu, Ke Yang, Li Bao. Targeting GABA signaling in the tumor microenvironment: implications for immune cell regulation and immunotherapy resistance. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1645718
|
| 7 |
Deyuan Zhong, Yuxin Liang, YaHui Chen, Yuhao Su, Qinyan Yang, Hongtao Yan, Xiaolun Huang, Ming Wang. Preoperative TACE with PD-1 inhibitors and TKIs in beyond “up-to-seven” hepatocellular carcinoma: a propensity score matched analysis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1657371
|
| 8 |
Yu Yang, Zhanping Guo. Prognostic value of Linc00662/miR-16-5p/FASN in cervical cancer and regulation of tumor progression. Hereditas 2025; 162(1) doi: 10.1186/s41065-025-00520-6
|
| 9 |
Junji Maeda, Motoki Furutani, Shunsuke Miyauchi, Mika Nakashima, Naoki Ishibashi, Takumi Sakai, Naoto Oguri, Shogo Miyamoto, Sho Okamura, Yousaku Okubo, Takehito Tokuyama, Noboru Oda, Taiichi Takasaki, Shinya Takahashi, Hidenori Aizawa, Daichi Shigemizu, Yukiko Nakano. RNA sequence analysis of differentially expressed genes in left atrial appendage thrombus. Journal of Thrombosis and Thrombolysis 2025; doi: 10.1007/s11239-025-03184-1
|
| 10 |
Zhenye Tang, Chenfei Zhou, Yinyin Xu, Zhizai Chen, Shuting Huang, Jing Chen, Ping Jin, Jiemei Hu, Shanyang He. Identification of anoikis-related tumor microenvironment characteristics and prognostic signature in ovarian cancer at bulk and single-cell levels. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03602-z
|
| 11 |
Ruoyu Jin, Qianhui You, Chenshi Li, Na Zhao, Chengyao Jia, Chinying Koo, Weiwei Zhang, Baonian Liu, Kaijian Huang. Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity. Drug Design, Development and Therapy 2025; : 7653 doi: 10.2147/DDDT.S545216
|
| 12 |
Chao Zhong, Zhaorui Cheng, Yuansen Shu, Xiaojuan Yang, Jia Hu, Ling He, Xiushen Li, Xu Xiang Chen, Yun Liu. FSTL1 is a prognostic marker and promotes invasion and metastasis of colon cancer. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03989-9
|
| 13 |
Tingbo Ye, Jizheng Liu, Chunying Wang, Ting Liu, Xianwei Zhang, Ying Luo, Jie Peng, Hongzhou Liu. Immunosuppression of HMOX1 contributes to metastasis and poor prognosis in glioma. Biochemical and Biophysical Research Communications 2025; 789: 152848 doi: 10.1016/j.bbrc.2025.152848
|
| 14 |
Fei Yan, Jingni Zhu, Qibing Wu, Yuanyuan Ren, Xinnian Yu, Zijian Sun, Yang Liu, Changjiang Sun, Yan Sun. Real-world first-line serplulimab therapy for advanced esophageal cancer: effectiveness, safety, and clinical implications. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1637458
|
| 15 |
Yazhen Huang, YanYun Meng, XiaoShan Lou, Doudou Feng, XiangLi Ling, Yang Jin, Xiangping Lin, Su Xie. The Modified Shuyu Pill Inhibits the Formation of Pre-Metastatic Niches in Triple-Negative Breast Cancer by Reducing the Number of Myeloid-Derived Suppressor Cells (MDSCs) via the JAK2/STAT3 Pathway. Breast Cancer: Targets and Therapy 2025; : 1213 doi: 10.2147/BCTT.S549554
|
| 16 |
Nattida Kampuang, Siriporn Chamniansawat, Pawin Pongkorpsakol, Supisara Treveeravoot, Narongrit Thongon. Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonists suppress colon adenocarcinoma HT-29 cells. World Journal of Gastrointestinal Oncology 2025; 17(12): 110736 doi: 10.4251/wjgo.v17.i12.110736
|